These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ANA negative SLE male patient with predominant pulmonary involvement. Shaikh YA J Coll Physicians Surg Pak; 2006 Mar; 16(3):239. PubMed ID: 16542614 [No Abstract] [Full Text] [Related]
10. [Long-term analysis of clinical disease activity and chronic organ damage in patients with systemic lupus erythematosus]. Rapp CA; Berner B; Müller GA; Reuss-Borst MA Z Rheumatol; 2002 Oct; 61(5):521-31. PubMed ID: 12399879 [TBL] [Abstract][Full Text] [Related]
11. [Systemic lupus erythematosus - Standards in 2015]. Aringer M; Schneider M Dtsch Med Wochenschr; 2014 Sep; 139(37):1813-6. PubMed ID: 25180995 [No Abstract] [Full Text] [Related]
12. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. das Chagas Medeiros MM; Bezerra MC; Braga FN; da Justa Feijão MR; Gois AC; Rebouças VC; de Carvalho TM; Carvalho LN; Ribeiro ÁM Lupus; 2016 Apr; 25(4):355-63. PubMed ID: 26405022 [TBL] [Abstract][Full Text] [Related]
13. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus. Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107 [TBL] [Abstract][Full Text] [Related]
14. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus. Lavalle-Graef A; Villegas-Acosta L; Lavalle C Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913 [TBL] [Abstract][Full Text] [Related]
16. [Bullous systemic lupus erythematosus]. Bacman D; Ostendorf B; Megahed M; Ruzicka T; Schneider M; Kuhn A Hautarzt; 2004 Apr; 55(4):392-5. PubMed ID: 15021938 [TBL] [Abstract][Full Text] [Related]
17. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Choi MY; Clarke AE; St Pierre Y; Hanly JG; Urowitz MB; Romero-Diaz J; Gordon C; Bae SC; Bernatsky S; Wallace DJ; Merrill JT; Isenberg DA; Rahman A; Ginzler EM; Petri M; Bruce IN; Dooley MA; Fortin PR; Gladman DD; Sanchez-Guerrero J; Steinsson K; Ramsey-Goldman R; Khamashta MA; Aranow C; Alarcón GS; Manzi S; Nived O; Zoma AA; van Vollenhoven RF; Ramos-Casals M; Ruiz-Irastorza G; Lim SS; Kalunian KC; Inanc M; Kamen DL; Peschken CA; Jacobsen S; Askanase A; Stoll T; Buyon J; Mahler M; Fritzler MJ Arthritis Care Res (Hoboken); 2019 Jul; 71(7):893-902. PubMed ID: 30044551 [TBL] [Abstract][Full Text] [Related]
18. Systemic Lupus Erythematosus for Primary Care. Kado R Prim Care; 2018 Jun; 45(2):257-270. PubMed ID: 29759123 [TBL] [Abstract][Full Text] [Related]
19. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests. Infantino M; Grossi V; Benucci M; Li Gobbi F; Damiani A; Manfredi M Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585 [TBL] [Abstract][Full Text] [Related]
20. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis]. Haake H; Köneke J; Amann K; vom Dahl J; Janssen U Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]